<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347818</id>
  <title nil="true"/>
  <common-name>(2s)-2-[[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]amino]-3-phenylpropanoic acid</common-name>
  <description>(2s)-2-[[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]amino]-3-phenylpropanoic acid is a chemical compound with the formula C28H25ClN2O5. With an average molecular weight of 505.00 g/mol, (2s)-2-[[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]amino]-3-phenylpropanoic acid is a heavy molecule.</description>
  <cas>76823-26-2</cas>
  <pubchem-id>3059589</pubchem-id>
  <chemical-formula>C28H25ClN2O5</chemical-formula>
  <weight>505</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:38:38Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:38:38Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NC(CC4=CC=CC=C4)C(=O)O</moldb-smiles>
  <moldb-formula>C28H25ClN2O5</moldb-formula>
  <moldb-inchi>InChI=1S/C28H25ClN2O5/c1-17-22(16-26(32)30-24(28(34)35)14-18-6-4-3-5-7-18)23-15-21(36-2)12-13-25(23)31(17)27(33)19-8-10-20(29)11-9-19/h3-13,15,24H,14,16H2,1-2H3,(H,30,32)(H,34,35)/t24-/m0/s1</moldb-inchi>
  <moldb-inchikey>YGBWTKPJKIUQGL-DEOSSOPVSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">504.1451996</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.6</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343711</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>(2s)-2-[[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]amino]-3-phenylpropanoic acid</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Indoles and derivatives</klass>
  <subklass>Benzoylindoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298155</sync-id>
  <structure-inchikey>YGBWTKPJKIUQGL-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000004400080001800000000400000040000000000000000080000100000000000000000000240000000100000004000000000000000000000000000000000000000000400000000000000000000020000000000100000200008000000000040000010080000040106000100000000000000100000000000000000000000000000040220000800000000000080080000000000100000000000000000000200000000000000000040000084000000000000000002000000000008100000080000000000000000000008040000000000010004000002000000220020000000000000000000800000040000000000400000000000008000000020004002000</structure-fingerprint>
  <structure-pattern-fingerprint>7014c2308d32864089001b608138a2001980140085852004803d20408224c9cc7c222854138000000100410800c00000046002a4c08d3261037e653980a04010c7130c0116d2161040901070137283000804859153211f3342040562502259061c28052f0848822160489480ddb4024d20868070812de10431192e6802510012124c00184ef8820808061250ca2c0008393d981244c09f8b5026082060c004a480d3101310b0c0200a040968057c3f104ac002028943084818a04a104cc04212a00002a404d80a3301808684547542900c010010434050200d60020428010300903049100889032411400413595220a20850043094c2042e5108108072400206</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:23Z</structure-indexed-at>
</compound>
